Engineering and Development

Customer Service and Support

Legal and Compliance

Human Resources

Product Management

President & CEO

EVP & CFO

Cytokinetics price target raised by $7 at BofA, here's why

RESTEM to Host R&D Day Highlighting its Next-Generation Immunomodulatory Treatment for Autoimmune and Inflammatory Diseases

Transcript : Cytokinetics, Incorporated Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 11

Led by ex-HI-Bio CEO, Braveheart pays $65M to challenge BMS for heart disease market

Senior Director, Drug Safety Operations

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors. The Senior Director of Drug Safety Operations will lead the Drug Safety operations, ensuring compliance with reporting requirements and collaborating on safety data and risk management for clinical trials.

Sign up with Google

Sign in with Google